Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data. (2016)
Attributed to:
Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1208/s12248-015-9840-7
PubMed Identifier: 26538125
Publication URI: http://europepmc.org/abstract/MED/26538125
Type: Journal Article/Review
Volume: 18
Parent Publication: The AAPS journal
Issue: 1
ISSN: 1550-7416